Standard of Care: Treating High Prolactin
At a Glance
The standard treatment for high prolactin usually begins with dopamine agonist medications like cabergoline, which effectively lower hormone levels and shrink prolactinomas. Surgery is generally reserved for tumors that resist medication, cause intolerable side effects, or threaten vision.
The standard of care for acquired hyperprolactinemia depends entirely on the underlying cause. Unlike many other tumors where surgery is the first step, most prolactin-secreting tumors are treated with medication first. This “medical-first” approach is highly successful, often shrinking tumors and restoring hormonal balance without the need for an operation [1][2].
The Treatment Decision Tree
Your care team will typically follow a specific logic to decide on your treatment path:
- If the cause is a Prolactinoma: Dopamine agonists are the first-line treatment [1].
- If the cause is Medication: The goal is to safely switch or adjust the drug causing the spike [3].
- If the cause is Systemic: Treating the underlying issue (like hypothyroidism) will usually fix the prolactin [4].
First-Line Medical Therapy: Dopamine Agonists
Dopamine agonists (DAs) mimic the natural dopamine in your brain that keeps prolactin in check. They are effective at both lowering hormone levels and shrinking the tumor itself [5][2].
- Cabergoline: This is the preferred choice for most patients. It is taken just once or twice a week and is more effective at normalizing prolactin than older medications [6][5].
- Bromocriptine: An older medication that is usually taken daily. While effective, it may be more likely to cause side effects like nausea [6][7].
Managing Day-to-Day Side Effects
While these medications are powerful, they can cause some short-term side effects such as nausea, dizziness, or feeling faint (especially when standing up quickly). To minimize these symptoms, doctors often recommend taking your pill at bedtime with a small snack so you sleep through the peak of the medication’s effects [6].
Important Safety Note: Because these drugs stimulate the brain’s reward system, a small number of patients may develop Impulse Control Disorders. This can manifest as sudden, compulsive urges to gamble, shop, or eat. It is vital to report any behavioral changes to your doctor immediately [8][9].
What to Expect: A General Timeline
Patients often wonder how quickly treatment works:
- Prolactin Levels: Often drop significantly or normalize within a few weeks of starting treatment [2].
- Symptom Relief: Restoring your period, libido, or stopping galactorrhea may take several months as your body’s systems ‘reboot’ [2][10].
- Tumor Shrinkage: Noticeable shrinkage on an MRI typically takes a few months to a year [2].
Managing Medication-Induced Elevation
If your high prolactin is caused by a psychiatric medication (like risperidone), your doctors must balance your mental health needs with your hormonal health.
- Switching: Your psychiatrist may suggest a “prolactin-sparing” antipsychotic like aripiprazole or quetiapine [3].
- Adding (Augmentation): If switching isn’t safe, adding a low dose of aripiprazole as an “adjunct” has the strongest evidence for lowering prolactin while keeping your primary treatment stable [11][12].
When is Surgery Necessary?
Surgery (typically transsphenoidal surgery through the nose) is usually secondary, but it is the right choice under specific conditions [1][13]:
- Resistance: The tumor does not shrink or prolactin doesn’t drop despite high doses of medication [13].
- Intolerance: The side effects of medication (like severe nausea or psychiatric symptoms) are too much to handle [1].
- Vision Loss: The tumor is pressing on the optic nerves, causing rapid or severe vision impairment [14].
- Cystic Tumors: Fluid-filled tumors (cysts) often don’t respond well to medication and may require surgical drainage [15][16].
Long-Term Monitoring
Treatment is not a “one-and-done” event. Most patients require ongoing monitoring:
- Blood Tests: To ensure prolactin stays in the normal range.
- MRIs: Periodically scheduled to track tumor shrinkage [2].
- Heart Health: For patients on high-dose or long-term cabergoline, occasional echocardiograms are recommended to ensure heart valves remain healthy [17][5].
Back to Home.
Common questions in this guide
Why is medication the first choice for treating a prolactinoma?
What are the side effects of cabergoline and bromocriptine?
How quickly will my prolactin levels and symptoms improve with treatment?
What if my high prolactin is caused by a psychiatric medication?
When is surgery necessary for high prolactin?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since my tumor is a prolactinoma, why are we starting with medication instead of surgery?
- 2.What is the starting dose for my cabergoline, and should we schedule an echocardiogram to check my heart valves before I begin long-term treatment?
- 3.If I experience side effects like nausea or mood changes, can we adjust the timing or dose of my medication?
- 4.If my hyperprolactinemia is caused by my current psychiatric medication, can we discuss adding low-dose aripiprazole instead of stopping my primary treatment?
- 5.How often will we repeat my MRI to see if the tumor is shrinking?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
The Role of Surgery in the Management of Prolactinomas.
Donoho DA, Laws ER
Neurosurgery clinics of North America 2019; (30(4)):509-514 doi:10.1016/j.nec.2019.05.010.
PMID: 31471058 - 2
Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas.
Auriemma RS, De Alcubierre D, Pirchio R, et al.
Frontiers in endocrinology 2019; (10()):327 doi:10.3389/fendo.2019.00327.
PMID: 31191454 - 3
Clinical outcomes and serum prolactin levels in patients with antipsychotic-induced hyperprolactinemia following different management strategies.
Sangngarm A, Werawattanachai C, Somrak K, et al.
International journal of psychiatry in clinical practice 2026; (30(1)):77-83 doi:10.1080/13651501.2025.2593315.
PMID: 41283705 - 4
Increase in Thyrotropin Is Associated with an Increase in Serum Prolactin in Euthyroid Subjects and Patients with Subclinical Hypothyroidism.
Sheikhi V, Heidari Z
Medical journal of the Islamic Republic of Iran 2021; (35()):167 doi:10.47176/mjiri.35.167.
PMID: 35505831 - 5
A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas.
Mishra R, Konar SK, Shrivastava A, et al.
Indian journal of endocrinology and metabolism 2021; (25(6)):493-506 doi:10.4103/ijem.ijem_338_21.
PMID: 35355923 - 6
Prolactinoma: Navigating the Dual Challenge of Side Effects and Treatment Strategies - A Comprehensive Review.
Yogeeta F, Rauf SA, Devi M, et al.
Annals of medicine and surgery (2012) 2024; (86(8)):4613-4623 doi:10.1097/MS9.0000000000002308.
PMID: 39118737 - 7
Prolactinoma and pregnancy: From the wish of conception to lactation.
Maiter D
Annales d'endocrinologie 2016; (77(2)):128-34.
PMID: 27130071 - 8
Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase.
De Wit LE, Wilting I, Souverein PC, et al.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2022; (58()):30-38 doi:10.1016/j.euroneuro.2022.01.113.
PMID: 35189453 - 9
Impulse control disorders and their relationship with psychopathology in patients treated with cabergoline for hyperprolactinaemia.
Zerbinati L, Cristilli G, Valier B, et al.
Pituitary 2026; (29(3)).
PMID: 42149330 - 10
An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
O'Sullivan SM, Farrant MT, Ogilvie CM, et al.
The Australian & New Zealand journal of obstetrics & gynaecology 2020; (60(3)):405-411 doi:10.1111/ajo.13070.
PMID: 31583693 - 11
Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses.
Jiang Q, Li T, Zhao L, et al.
Frontiers in psychiatry 2024; (15()):1337274 doi:10.3389/fpsyt.2024.1337274.
PMID: 38505795 - 12
Management of antipsychotic-induced hyperprolactinemia.
Tewksbury A, Olander A
The mental health clinician 2016; (6(4)):185-190 doi:10.9740/mhc.2016.07.185.
PMID: 29955468 - 13
Clinical characteristics and surgical outcome of prolactinoma in patients under 14 years old.
Zhao Y, Jin D, Lian W, et al.
Medicine 2019; (98(6)):e14380 doi:10.1097/MD.0000000000014380.
PMID: 30732174 - 14
Vision Outcomes Following Endoscopic and Microscopic Transsphenoidal Resection of Sellar/Parasellar Lesions - A Systematic Review of the Literature.
Lesha E, Dugan JE, Milton C, et al.
World neurosurgery 2026; (211()):125044 doi:10.1016/j.wneu.2026.125044.
PMID: 42128343 - 15
Significance of surgical management for cystic prolactinoma.
Ogiwara T, Horiuchi T, Nagm A, et al.
Pituitary 2017; (20(2)):225-230 doi:10.1007/s11102-016-0766-6.
PMID: 27757801 - 16
Surgical management considerations in cystic prolactinomas-a single center case series.
Nevzati E, Chatain GP, Carr SB, et al.
Endocrine 2020; (67(1)):58-66 doi:10.1007/s12020-019-02076-8.
PMID: 31773633 - 17
Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine.
Clausen MF, Rørth R, Torp-Pedersen C, et al.
BMC cardiovascular disorders 2021; (21(1)):622 doi:10.1186/s12872-021-02439-y.
PMID: 34963443
This page provides educational information on standard treatments for high prolactin. It does not replace professional medical advice. Always consult your endocrinologist or primary care provider about your specific diagnosis and treatment plan.
Get notified when new evidence is published on acquired hyperprolactinemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.